Viral Hepatitis Prevention Monthly Newsletter

ISSUE NUMBER EIGHT • May 2014

White Wide Section DividerUpdated BannerWhite Wide Section Divider

Hepatitis C Training Available

The Indiana Viral Hepatitis Prevention Program and HCVadvocate.org are working together to host a one-time only Hepatitis C Training Workshop on Friday, May 16th, 2014 at the Fort Harrison State Park INN. The Training is free and will cover hepatitis C from the liver to treatment but, space is limited and will be filled on a first come first serve basis.  For more information about the training, including how to register, please send an email to Brittany Gross at bgross@isdh.in.gov The deadline to register is Monday, May 5th, 2014. 

Green Section Divider PNG

Spotlight On...

May is Hepatitis Awareness Month!  

o    The Indiana State Department of Health (ISDH) will join the Centers for Disease Control and Prevention (CDC) in celebrating Viral Hepatitis Awareness month by highlighting one viral hepatitis infection each week. There will be internal promotion, website and social media prevention messages.

o    Check out the Viral Hepatitis Prevention webpage at http://www.in.gov/isdh/25797.htm to take a free Hepatitis Risk Assessment, developed by the CDC.

o    The ISDH is on social media!  Check out our twitter account @StateHealthIN and like the Facebook page at the ISDH for additional information on Hepatitis and Hepatitis Awareness Month.  For questions about social media, please contact the Office of Public Affairs at opa2@isdh.in.gov.

o    Remember that Monday, May 19th is National Hepatitis Testing Day.The CDC would like to know about any testing events planned in Indiana and will promote your testing event on their specific website.  To register your testing day event, click here. 

Once you have registered your event, it will be displayed on an interactive CDC sponsored webpage, allowing people to look up events in their area.  Click here to check out the website. 

o    The CDC has developed and released e-cards on hepatitis that can be sent to friends, family or patients. To access the e-cards, click here. 

Green Small Divider

Hepatitis Resources

ACT First: Free On-line Hepatitis Course for Primary Care Clinicians 

The American Associate for the Study of Liver Diseases (AASLD) has launched two news on-line courses on Heaptitis B and C, specifically for Primary Care Clinicians. ACT-First will help improve providers’ knowledge and clinical skills in hepatology. Physicians will learn which patients to screen for liver diseases, how to screen, what to do in the patient with positive serologies, what to tell the patient, and how to decide who is a candidate for therapy.  To read more and access the trainings click here.

Green Section Divider PNG

Viral Hepatitis Updates & News

Gilead Pressured to Cut Drug's Price

Express Scripts Holding Co., a pharmacy-benefit manager that handles more than 1 billion prescriptions a year in the U.S., is ratcheting up its effort to force Gilead Sciences to cut the $84,000 price of its new hepatitis C pill Sovaldi.

Express Scripts plans to ask clients, composed of national employers, health insurance plans and government agencies, to join a coalition that would stop using Sovaldi once a rival medicine is approved for the U.S.

To read the full article, click here.

Entecavir Label Expands Indication for Children with Heaptitis B Infection.  

In March, 2014, the U.S. Food and Drug Administration approved new labeling for Baraclude (entecavir) to expand the patient population for treatment of chronic HBV infection to include children two years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. To read more, click here

Experimetnal Drug for Hepatitis C has Cure Rates at 95 Percent

Researchers report that an experimental drug has cured more than 95 percent of patients infected with hepatitis C, including some who failed other treatments.

If it wins approval from the U.S. Food and Drug Administration, this new drug, called ABT-450, could potentially compete with another innovative hepatitis C medication.  To read more, click here.  

If it wins approval from the U.S. Food and Drug Administration, this new drug, called ABT-450, could potentially compete with another innovative hepatitis C medication.  To read more, click here.  

*Please not that the above information is for educational purposes only and is not an endorsement of any drug or drug company.

IN THIS ISSUE

Small Green Section DividerSmall Green Section Divider

UPCOMING EVENTS

Walk for Hepatitis C

Always Reflecting Kindness (ARK) is sponsoring a walk for hepatitis C to Help, Educate, Promote and Connect.  

Where

Southland Community Church
5800 W. Smith Valley Rd.
Greenwood, IN 46142

When

Saturday, May 17, 2014

Agenda

8:30–9:30 AM — Registration
9:30–11:30 AM — Walk
11:00–Noon — Post Walk

For more information visit the ARK website at www.hepcark.org.  

Hepatitis Testing Day Event

Where

Blackford County Health Department (BCHD) located at

506 E Vancleve St.                   Hartford City, IN 47348  

When

Monday, May 19, 2014       

8:30 am-6:00 pm

Please call 765-348-4317 for an appointment

Small Green Section Divider